how to glp 1 drugs work GLP-1 receptor agonists How GLP-1 Medications Actually Work

Murielle Veniant-Ellison, who heads Amgens obesity research and development, said that in addition to the drug binding to the GLP-1 receptor, its antibody also targets the GIP receptor, like tirzepatide

Funding The author(s) declare financial support was received for the research, authorship, and/or publication of this article

GLP-1 agonists work by mimicking the actions of the naturally occurring hormone in the body

Furthermore, when transitioned to metformin maintenance post-discontinuation, some patients exhibit limited weight regain and maintain lower body weight and hepatic fat levels compared to baseline (123)

In comparison to sitagliptin, semaglutide has been shown to significantly reduce the 12-month risk of cognitive deficits, dementia, and epilepsy.[63] In PCOS, a meta-analysis indicated that exenatide and liraglutide exhibit stronger effects on insulin sensitivity and BMI reduction than metformin.[71] A 24-week study found that exenatide led to a significantly higher rate of spontaneous pregnancies and more regular menstrual cycles compared to metformin.[72] Although rapid weight loss in some contexts is associated with an increased risk of frailty fractures, GLP-1RAs may mitigate this effect.[73, 74] Both exenatide and dulaglutide were found to increase bone mineral density, while lixisenatide and liraglutide were associated with a reduced risk of fractures, suggesting differential effects of GLP-1RAs on bone metabolism.[74] OTHER CONSIDERATIONS Side effects and adverse events related to GLP1-RAs While GLP-1RAs are credited with a growing list of health benefits, they have also been associated with a wide variety of adverse effects that may vary among agents.[6, 21] Common side effects include nausea, vomiting, diarrhea, mild tachycardia, and injection site reactions.[75] A pooled analysis of 33 clinical trials (n=13,548) found an increased risk of treatment discontinuation due to gastrointestinal effects such as nausea and vomiting.[6] Potential adverse events include pancreatitis, cholelithiasis, and dehydration.[76] Rodent studies and one observational study in humans have raised concerns about GLP-1RAs impact on thyroid cancer risk